KiTZ Symposium 2019 Talks 10

  • 474 views

  • 0 Kommentare

  • 0 favorites

  • admin admin
  • 62 Medien
  • hochgeladen 13. Februar 2019

Session 7
Michael Cox: Developing Inhibitors Against Rare Oncogenic Kinases
Mark Cowley: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer
Pratiti (Mimi) Bandopadhayay: Cell-cycle and neuronal differentiation programs mediate response to BET-bromodomain inhibitors in MYC-driven medulloblastoma
Frank Westermann: Novel metabolic dependencies of MYCN-driven childhood neuroblastomas: Cyst(e)ine as a promising therapeutic target
Holger Lode: Passive GD2 directed immunotherapy upregulate the PD1/PD-L1 immune checkpoint in neuroblastoma: a rationale for combination therapy

Tags:

Mehr Medien in "Kommunikation und Marketing"

0 Kommentare

Es gibt noch keine Kommentare. Fügen Sie einen Kommentar hinzu.